The stroke rate among adults and children with sickle cell disease in the U.S. is rising, indicating a need for greater ...
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help advance her work on programs for sickle cell disease (SCD) in her home country.
Infections in sickle cell disease can be problematic and even fatal. Columnist Oluwatosin Adesoye, a patient and doctor, has ...
As a health professional and sickle cell patient, I’m constantly driven to create awareness about the disease. My motivation transcends professional duty; it’s a personal quest to make a difference.
The women's sorority plans to donate $2 million by 2028 to St. Jude Children's Research Hospital, which offers care at no ...
Sickle cell carriers are at a slightly increased risk of blood clots, but the overall risk is still low, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback